Latest Insights - page 44 | BiopharmaTrend

Orbis Medicines Raises €90 Million For Oral Macrocycles, Backed by Novo Holdings and Eli Lilly

Denmark-based Orbis Medicines has raised €90 million ($93.2 million) in a Series A financing round to advance its development of oral macrocycle drugs. The round was co-led by Novo Holdings …

Continue ›››

James Wilson's GEMMABio Secures $34 Million to Advance Gene Therapy

Philadelphia-based GEMMA Biotherapeutics (GEMMABio), a newly established therapeutics company led by gene therapy pioneer Dr. Jim Wilson, has announced the successful closure of a $34 million seed funding round. The …

Continue ›››

Irish AI Startup Focused on Natural Peptide Discovery Secures $42M

Nuritas, an Irish biotech company specializing in AI-powered peptide discovery from natural sources, announced it has raised $42 million in a Series C funding round. The company plans to use …

Continue ›››

Chemistry CROs at a Crossroads: How SpiroChem Is Adapting to Market Shifts in 2025 and Beyond

Alphabet's AI Spinoff Raises $300M at $5.3B Valuation Amid Biopharma Partnerships

SandboxAQ, a Palo Alto SaaS startup, operating at the intersection of artificial intelligence and quantum technology, announced it has raised over $300 million in funding, bringing its pre-money valuation to …

Continue ›››

BioAge Labs and Novartis Ink $500M Deal to Tackle Aging-Related Diseases

BioAge Labs, a clinical-stage biopharmaceutical company developing therapies targeting the biology of aging, announced a multi-year collaboration with Novartis worth over $500 million. The partnership aims to identify and validate …

Continue ›››

After Raising $13M, AI-Driven Protein Biotech Appoints Board Chair

ExpressionEdits, a biotechnology company leveraging AI and proprietary intronization technology to optimize protein expression, announced the appointment of Dr. Paul Bolno as Chair of its Board of Directors. Dr. Bolno, …

Continue ›››

Noetik Announces Foundation Models of Spatial Biology for Precision Oncology

After securing $40 million in August 2024, Noetik—an AI-native biotechnology company—announced in a recently released technical report the launch of OCTO-VirtualCell, a next-generation AI model designed to reveal how cells …

Continue ›››

Bristol Myers Squibb Grants $25M for insitro’s Milestone in ALS Target Discovery

insitro has secured $25 million in milestone payments from Bristol Myers Squibb for reaching discovery milestones and identifying the first novel genetic target for amyotrophic lateral sclerosis. This achievement builds …

Continue ›››

Sanofi Opens Call for Proposals for 2025 iNext Awards North America

Sanofi has opened pre-proposal submissions for its 2025 iNext Awards, a pioneering program aimed at advancing high-risk, high-reward innovations in immunoscience. This initiative, led by Sanofi's External Scientific Affairs (ESA) …

Continue ›››

Gameto Achieves First Live Birth Using Egg Maturation Technology Outside the Body

Gameto, a biotechnology company focused on fertility treatments, announced the world’s first live birth using Fertilo, its ovarian support cell (OSC) technology that matures eggs outside the body.

Continue ›››

Legal and Governance Considerations in AI for Drug Discovery: New Paradigms and 2025 Outlook

Just in time for 2025 prediction season, a survey of the emerging AI drug discovery landscape, prepared by Chris Bradbury, has been making the rounds—and with good reason. The survey …

Continue ›››